Aytu BioScience Inc (AYTU)

CONSUMER DISCRETIONARY: CONSUMER SERVICES
SIC: PHARMACEUTICAL PREPARATIONS

373 INVERNESS PARKWAY ENGLEWOOD, CO 80112

Aytu BioScience, Inc. operates as a specialty healthcare company. The Company concentrates on acquiring, developing, and commercializing products focused primarily on sexual disfunction disorders, urological cancer, urinary tract infections, and male infertility. Aytu Bioscience serves customers worldwide.

Data as of 2021-07-19 09:14:46 -0400
Market Cap106.723 Million Shares Outstanding25.171 Million Avg 30-day Volume1.501 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE0.06 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.66533 52-week High/Low15.5 / 4.21 Next Earnings Date2021-09-20 Price to Cash FLow (P/CF) -4.5727
Data provided by IEX Cloud
View SEC Filings from AYTU instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 1 -100.0% 0 (0.0%) 1 (0.06%) -100.0%
Funds Holding: 71 50 42.0% 15 (0.88%) 7 (0.41%) 114.29%
13F shares: 6.32 Million 4.307 Million 46.73% 2.597 Million 2.969 Million -12.53%
% Ownership 35.3403 24.974 41.51% 14.522 17.2141 -15.64%
New Positions: 27 10 170.0% 9 4 125.0%
Increased Positions 24 31 -22.58% 3 3 0.0%
Closed Positions 5 26 -80.77% 1 6 -83.33%
Reduced Positions 6 3 100.0% 3
Total Calls 45.432 Thousand
Total Puts 17.625 Thousand
PUT/CALL Ratio 0.39
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AYTU (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AYTU BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DISBROW JOSHUA R. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
897,506 2021-04-16 1

MACALUSO MICHAEL

  • Director
208,079 2021-04-16 1

DOCKERY CARL

  • Director
188,805 2021-04-16 1

CANTRELL GARY

  • Director
204,089 2021-04-16 1

DONOFRIO JOHN JR.

  • Director
203,071 2021-04-16 1

HECHT BETH

  • Director
9,052 2021-04-08 2

MCLAUGHLIN GERALD W.

  • Director
31,401 2021-04-08 2

EISENSTADT RICHARD I CHIEF FINANCIAL OFFICER

  • Officer
13,734 2021-03-31 2

ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL MASTER FUND LTD.

BOYD STEVEN

  • Director
1,342,378 2021-03-20 2

GREEN DAVID A CHIEF FINANCIAL OFFICER

521,250 2020-06-08 0

MEHTA KETAN BHUPATRAI

75,000 2020-06-08 0

CERECOR INC.

  • 10% Owner
9,713,068 2020-04-15 0

DISBROW JARRETT CHIEF OPERATING OFFICER

  • Officer
359,475 2018-10-24 0

GOULD GREGORY A CHIEF FINANCIAL OFFICER

  • Officer
340,231 2017-03-16 0

MCGRAEL JONATHAN H VP OF COMMERCIAL OPERATIONS

  • Officer
140,000 2016-07-07 0

AMPIO PHARMACEUTICALS, INC.

  • 10% Owner
1,226,407 2015-12-01 0

WIEGAND JAMES B PRESIDENT

  • Officer
  • Director
  • 10% Owner
2,340,659 2014-03-19 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AYTU BIOPHARMA INC AYTU 2021-07-23 22:15:03 UTC -1.4559 1.5359 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 21:45:03 UTC -1.4559 1.5359 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 21:15:03 UTC -1.4559 1.5359 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 20:45:03 UTC -1.4265 1.5065 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 20:15:05 UTC -1.4265 1.5065 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 19:45:03 UTC -1.4265 1.5065 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 19:15:03 UTC -1.4265 1.5065 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 18:45:03 UTC -1.4162 1.4962 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 18:15:03 UTC -1.4162 1.4962 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 17:45:03 UTC -1.4162 1.4962 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 17:15:02 UTC -1.4162 1.4962 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 16:45:02 UTC -1.4162 1.4962 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 16:15:03 UTC -1.4162 1.4962 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 15:45:02 UTC -1.4162 1.4962 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 15:15:03 UTC -1.4162 1.4962 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 14:45:03 UTC -1.4048 1.4848 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 14:15:03 UTC -1.4048 1.4848 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 13:45:03 UTC -1.4048 1.4848 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 13:15:03 UTC -1.4048 1.4848 750000
AYTU BIOPHARMA INC AYTU 2021-07-23 12:45:03 UTC -1.4048 1.4848 700000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund AYTU -924.0 shares, $-7022.4 2021-03-31 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund AYTU -1187.0 shares, $-9021.2 2021-03-31 N-PORT
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund AYTU -12539.0 shares, $-83008.18 2021-04-30 N-PORT

Short Position History (International Only)

Holder Net Short Position Position Date Origin
Bronte Capital Management Pty Ltd Aytu BioScience Inc 0.03% 2021-01-25 GERMANY
Bronte Capital Management Pty Ltd Aytu BioScience Inc 0.53% 2020-12-11 GERMANY

Elevate your investments